# DESCRIPTION

## RESEARCH STATEMENT PURSUANT TO 37 CFR 401.14(a)(b)(1)

## FIELD

## BACKGROUND

## SUMMARY

## DETAILED DESCRIPTION

### Definitions and Interpretation

### Description of Aspects of the Disclosure

### Doses, Dosage Forms, and Methods of Treatment

### Bacterial Infections

## EXAMPLES

### Example 1. Development of SAFIRE, a Screen for Anti-Infectives Using Fluorescence Microscopy of IntracellulaR Enterobacteriaceae

### Example 2. Identification of Small Molecules that Reduce Salmonella Load in Macrophages

### Example 3. Top Hits do not Inhibit Bacterial Growth in Broth

### Example 4. Three Compounds Inhibit Efflux of Fluorescent Dyes

### Example 5. EPMs do not Appear to Disrupt the Proton Motive Force

### Example 6. The Three EPMs are Potent and Structurally Diverse

### Example 7. EPMs Sensitize S.Tm to Host Antimicrobial Peptides

### Example 8. EPM35 Increases Sensitivity of Multi-Drug Resistant S.Tm to Tetracycline

### Example 9. Three Compounds Increase Salmonella Accumulation of an Efflux Pump Substrate

## Materials and Methods

### Bacterial Strains

### Cell Culture

### Bacterial Infections for SAFIRE and CFU Plating

### Real-Time Reverse Transcription PCR

### Image Acquisition, MATLABÂ®-Based Screening Analysis, and Hit Selection

### Cytotoxicity Assays

### Broth Activity Assays

### Efflux Assays

### Swimming Assays

